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Geriatrics is an applied science as its practice is an art of medicine. As a scientific 
discipline, there exists a potential race for measurements. Frailty stands as among 
poorly defined concepts in geriatric medicine. There are philosophical, circumstan-
tial, and practical justifications behind this rather seemingly clinical tragedy. This 
chapter contributes toward reliability and validity aspects of currently applied frailty 
scales and indicators across different population base. It acknowledges the contribu-
tion of Fried’s frailty scale. It also describes different frailty scales and indicators 
tested in America, Europe, and Asia. Lastly, the chapter contrasts the popular belief 
behind applications of Cronbach’s α coefficient of test scores for reliability assess-
ment in clinical research. Other research gaps are also highlighted including merging 
clinical research findings in geriatrics with psychosocial aspects under the emerging 
field of geropsychology. It also proposes a solution for usage in future studies that 
aim at assessing reliability of test scores in clinical and biomedical sciences.
Keywords: frailty, reliability, validity, multimorbidity, index, scale
1. Introduction
Geriatric medicine is a relatively younger sub-specialty of medicine. Unlike 
fields like general internal medicine or surgery, that are known to have existed since 
antiquity, geriatrics has gained significant popularity, in orthodox medical practice, 
around the second half of the twentieth century. Geriatrics is an applied science just 
as its practice is an art of medicine. For that matter, there exists a potential race for 
measurements. It follows logic therefore that for geriatric medical conditions and 
practice to be acceptable among scientists, it needs unified codes that are measur-
able. This chapter will provide basic aspects associated with measuring variables 
that are customarily prevalent in geriatric wards and corridors throughout the 
world. Specifically, it analyzes the reliability and validity of different scales of the 
commonest concept of frailty among senior citizens the world over.
The clinical characterization, of modern geriatric medicine, owes much to the 
pioneering work, of Professor Bernard Isaacs back in the 1960s. It was Isaacs who is 
credited in public literature, to have coined the term “geriatric giants,” in common 
usage, to geriatricians the world over to date [1]. Simply stated, he referred “geriatric 
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giants” to conditions of immobility, instability, incontinence, and impaired memory/
intellect that are relatively common, on statistical grounds, among senior citizens of 
any human society [1]. From 1960s onward, the conditions characterizing geriatric 
giants have changed several times, and currently used mainly among scholars and 
clinicians alike, in its modified form, as per Professor Mary Tinetti’s keynote address 
of Geriatric 5Ms, at the Canadian Geriatric Society conference, back in April 2017 
[2]. She addressed the Geriatric 5Ms to comprise the Mobility, Mind, Medications, 
Multi-complexity, and Matters most [2]. It must be understood that most of this 
characterization refers to measurable constructs that defines core aspects of geriatric 
medical research and practice, initially coined as geriatric giants by Isaacs in 1965.
There exists a lot of confusion in geriatric medicine to date, regarding the 
measurable construct of geriatric giants [3–7]. Part of this confusion has basis from 
failure to achieve standard definitions from its components. This is because, in 
almost all cases, disease conditions among senior citizens, unlike other groups in 
the population pyramid, tend to present atypically on clinical grounds. Whereas the 
exact cause of this trend among senior citizens is still ill understood, there exists 
evidence for a common pathway, originating from different organ systems, in etio-
pathogenesis of diseases in the elderly. Moreover, quite often there is also a discon-
nect between the original site of malice and the clinical presentations for symptoms 
and signs of pathologic conditions thereafter. The immediate effect of this rather 
anomalous conundrum is the rather bizarre presentations of most common clinical 
conditions, seen among senior citizens, as well as recorded in their morbidity and 
mortality statistics throughout the world.
Atypical presentation in the elderly can be exemplified, say by a Nonagenarian 
lady, presenting to the emergency department of a typical hospital, with symptoms 
and signs suggestive of acute confusional state like delirium, caused by Escherichia 
coli infection in her urinary tract. As it is commonly the case, once her bladder 
cystitis/urethritis is treated, using relatively simple treatment pathways, the acute 
confusional state disappears. The observation given, justifies not only the atypical 
nature of presentation, to most geriatric illnesses, but also the multiple organo-
systemic involvement, in their pathogenesis. Besides, growing characterization of 
emotional, social, and cognitive aspects of aging is paramount in modern clinical 
practice. There are several theories and postulates that endeavor to link the interplay 
of the mind (and the central nervous system) in multisystemic etiopathogenesis of 
Geriatric 5Ms. The theories and postulates have evolved into a new sub-specialty 
named geropsychology. The details of which will be discussed further in the discus-
sion section. However, to the betterment of science, there exists palpable evidence 
that probably the so-called Geriatric 5Ms has achieved a unified goal of standard-
izing the measurable construct of geriatric giants. It is on this basis that this chapter 
finds its pivot, on the attributable last aspect of Matters most, referred to as Frailty.
Frailty is a poorly defined syndrome almost exclusively confined to the elderly 
population. There are dozens of descriptions given for frailty [8–15]. All of them 
were made for specified frameworks of interest by their original authors. On 
pedagogic sense, none could be used systematically, without a pinch of doubt, to 
any destitute clinician/researcher. However, out of dozens of frailty definitions 
available, the one proposed by Fried and colleagues in Cardiovascular Health Study 
Collaborative Research Group back in 2001 [13] is the most widely applied frame-
work by clinicians/researchers in bio-gerontologists the world over. The underlying 
scientific framework for applying frailty syndrome to be discussed in this chapter 
has taken into account the famous fact derived by Sir George Box’s seminal paper 
back in 1978 that all models are wrong but some are useful [16] in its philosophical 
sense. It is neither the intention of this chapter nor anywhere in the mind of its 
author to market the Cardiovascular Health Study Collaborative Research Group’s 
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frailty postulate. Rather, and I do believe it to be safe, the plan is to sparingly appre-
ciate strengths and weaknesses of some of these useful concepts, via estimation of 
their internal consistency and content validity in each of them. Thus, this chapter 
will guide the reader through reliability and validity aspects of clinicopathological 
features associated with frailty syndrome in senior citizens.
2. Reliability of frailty models in elderly population studies
Geriatrics, as a branch of clinical sciences, is a scientific discipline as physics or 
chemistry is to natural sciences. To that end, measurements are the core aspect for 
its sustainability. It is under this framework that most frailty scales are available the 
world over to date, and in future shall be assessed. Technically, assessing the quality 
aspects of the scale takes mainly two domains, namely, reliability and validity. Taken 
simply, reliability assessment refers to the process of determining the extent to which 
a measurement of a phenomenon provides stable and consistent results [17]. This 
definition, though adopted from Carmine and Zeller’s publication of 1979 [17], who 
worked in the field of psychometrics, is as applicable, in its entirety to frailty scale 
assessment, as it was intended in assessing psychometric scales. Thus, whereas the 
intention here is to adopt quantifiable and logically consistent manner for reliability 
assessment of frailty scales, it is by no means the intention of the author to sales pitch 
the methods discussed nor should it be conclusive that the method described in this 
chapter is the only mechanism of achieving reliability assessment. To ensure clarity in 
this endeavor, the end of the chapter will also contain some vivid shortcomings and a 
potential solution to the reliability assessment method described in this chapter.
2.1 Internal consistency assessment of frailty scales used in elderly population
There are various ways of assessing reliability index of any given phenomenon/
scale in nature. Some are well known in literature, and there are probably many oth-
ers in production pipelines for usage in future. However, the most popular methods 
include test-retest reliability, split-half reliability, and internal consistency reli-
ability tests. Out of these, this chapter will deal with internal consistency reliability. 
The decision to do so is derived from its conceptual meaning as opposed to the rest. 
Simply stated, internal consistency refers to the extent to which a measurement of 
a scale provides stable and consistent results across a specified condition [17]. One 
rule is important to be mentioned here, in that all accounts of assessing reliability 
of any given scale, the reliability score to be obtained is not reflective of a constancy 
but rather a mere statistic for a given test result. This translates to the fact that a 
given scale may end up with different scores, under different elderly population 
conditions, dependent on a number of factors, some known (e.g., test settings and 
gender) and others unknown even to the test itself. Thus, caution to the interpreta-
tion of the test scores is highly warranted.
2.1.1 Clinical Frailty Scale
Clinical Frailty Scale (CFS) is a clinical judgment-based tool (originally designed 
as an epidemiological tool) to screen for frailty and other adverse health events in 
opposition to fitness in older aged population. It is a direct replica of a frailty index 
that was part of the original design aspect of the first part of Canadian Study on 
Health and Aging (CSAH), with the aim of characterizing cognitive impairment 
and other important health issues, designed as a prospective 5-year follow-up of 
10,263 people aged at least 65 years back in 1991 [18, 19]. At the time of going to 
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press, the Clinical Frailty Scale is composed of a 9-point scale, that was made public 
in 2007, an improvement from the original scale of a 5-point scale originally pub-
lished in 2005 [20]. It was originally developed in the second half of the Canadian 
Study of Health and Aging (CSHA) as a quick means to assess frailty and other 
senile physical and mental challenges past clinical assessment [20]. The conceptual 
framework of the Clinical Frailty Scale relies on the “fitness and frailty” model, 
and the scale was designed by adopting the mechanism from Streiner and Norman 
[21]. It is for all practical purposes, not a questionnaire but a quantified summary 
write-up of an elderly overall health status in relation to mortality risks. Internal 
consistency scores for Clinical Frailty Scale among elderly population across differ-
ent geographical areas are provided in Table 1.
2.1.2 Edmonton Frail Scale (EFS)
Edmonton Frail Scale, an effort first conceptualized by Darryl Rolfson while 
at the University of Alberta, Canada back in 1999, was presented for the first 
time to peer review at the Canadian Geriatric Society in Edmonton, Canada, in 
2000 [25]. Ever since its first time in press, the scale has been applied in research, 
educational and clinical settings for quantitative frailty assessment among senior 
citizens [15, 26–33]. Edmonton Frail Scale consists of nine domains and 11 items. 
The initial scale devised by Rolfson at Edmonton had 10 domains [25]. Each com-
ponent may have a score of 0, 1, or 2 signifying normal health, mild/moderate 
impairment, or severe impairment, respectively. Domains include general health 
status; cognitive status; medication use; presence of social support; incontinence; 
nutrition and mood; functional dependency; and functional performance test 
[25]. The total scores are also classified into no frailty (0–3 points); pre-frailty 
(4–5 points); frailty (6–8 points), and severe frailty (9–17) [26]. The internal 
consistency scores of Edmonton Frail Scale for senior citizens across different 
geographical settings are as reported here in Table 2.
2.1.3 Groningen Frailty Indicator
Groningen Frailty Indicator (GFI) is a 15-item indicator for assessment of frailty 
developed by Professor Steverink and his colleagues at the University of Groningen, 
The Netherlands, first published in 2001 [34]. The internal consistency findings of 
GFI are as summarized in Table 3.
2.1.4 Tilburg Frailty Indicator
Tilburg Frailty Indicator (TFI) is a questionnaire for screening frail community 
dwelling older people that includes self-reported information, originally tested and 
validated from an elderly community of Roosendaal in The Netherlands, based on 
Country/region Cronbach’s α-reliability score (95% C.I.) Settings
1. Australia [22] 0.76 (0.7–0.81) Perioperative (hospital-based)
2. Canada [20] 0.97 (not given) Community-based
3. Singapore [23] 0.91 (0.86–0.95) Hospital-based
4. Turkey [24] 0.811 (not given)* Outpatient clinic (hospital-based)
*p-value cited as <0.001.
Table 1. 
Internal consistency scores for Clinical Frailty Scale across elderly population from different geographical areas.
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a working framework in development, developed by a team of Dutch scientist first 
published in 2009 [38]. Tilburg Frailty Indicator is unique among frailty indicators, 
in that it includes multiple domains of human functions but selectively excludes 
disability [38]. TFI consists of two parts, namely, multimorbidity and frailty 
domains. The first part (designated as part A) contains 10 questions on determi-
nants of frailty in relation to disease states, while the second part is solely on frailty 
aspects [38]. The internal consistency score ratings of TFI across studies from 
different geographical areas are given in Table 4.
3.  Validity aspects of frailty scales and indicators used in elderly 
population
Much as reliability may be loosely assumed to be synonymous to precision in 
measurements, it follows a natural pattern then to ensure validity by the assumption 
Country/region Cronbach’s α-reliability score (95% C.I.) Settings
1. Canada [25] 0.62 Hospital/clinic based
2. Ireland [31] 0.41 Hospital based
3. Italy [26] 0.98 Hospital based
4. Poland [28] 0.709 Hospital based
5. China [33] 0.95 Hospital based
6. Canada [20] 0.97 Hospital based
Table 2. 
Internal consistency scores for Edmonton Frail Scale across senior citizens from different geographical areas.
Country/region Construct validity index Settings
1. The Netherlands [35] 0–1: disorder (median, range): 2, 1–4
2: (median, range): 4, 3–6
3: (median, range): 6, 4–8
Community-based
2. The Netherlands [36] GFI ≥ 4 Community-based
3. Romania [37] GFI score = 0.746 Physician-based
Table 3. 
Construct validity scores for Groningen Frailty Indicator across senior citizens in different geographical areas.
Country/region Construct validity index Settings




2. The Netherlands [38] Social domain: r = −0.35–0.71 (P < 0.001)
Physical domain: r = −0.43–0.62 (P < 0.001)
Psychological domain: r = −0.19–0.46 (P < 0.001)
Social domain: r = 0.29–0.96 (P < 0.001)




3. Italy [40] Social domain: r = 0.25 (P < 0.001) Community-based
Table 4. 
Construct validity scores of Tilburg Frailty Indicator across senior citizens in different geographical areas.
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of accuracy. It must be understood that geriatrics, just as other branches of clinical 
medicine, is essentially an applied science field. To this end, the reader is cautioned 
against making substantial error in reasoning, that of assuming measurement 
exactness of constructs made in its clinical measurements, just as natural scien-
tists make, in say reaction time in subjects like physics or chemistry. It is on this 
basis, that all aspects of validity, discussed in this chapter, constitute a number of 
assumptions, some of them may be hard to prove, even when considered useful 
in the stated models. For instance, since most validation processes in constructing 
frailty scales and indicators consisted of a number of items, the assumptions made 
are such that those items, when taken collectively, refer to a construct of frailty, and 
that when applied to humans in their contextual nature, can distinguish those who 
are frail from those who are not. This section will deal with one important form of 
validity measurement, that of construct validity at most [41].
Construct validity is a way of measuring a disposition/character/trait/belief 
such that its accuracy can be estimated with quantifiable degrees of confidence. 
In simplistic fashion, it is a way of measuring a test for what it claims to quantify. 
Construct validity differs from other forms of validity in applied sciences, namely, 
criterion and content validity, since in construct validation, there is an aspect of 
quantifying the quality of a measuring instrument toward what it claims to mea-
sure. Thus, for all practical purposes, this chapter will endeavor to quantify aspects 
hypothesized to assess frailty, as applied to the community of senior citizens living 
in different geographical communities. This notion, inter alia, follows the appre-
ciable level of acceptance in reliability indices prior to its undertaking, lest of that, 
it may be deemed invalid in practice. In this sub-section, an analysis of different 
frailty scales/indicators in construct validity will be determined here underneath.
4.  The triumph and controversies surrounding reliability and  
validity of frailty scales/indicators in elderly population
It is important to underscore the importance of association between what is 
characterized as frailty and increased susceptibility to ill health among humans 
of advanced age. From the earlier sections of this chapter, an account of the term 
frailty has been made. However, it is important to analyze those numbers, in a bid 
to express not only what they suggest but also not to overexpress their usefulness in 
science. One important caution needs special attention here in that myself as a clini-
cal researcher, positively influenced by biased affection to make judgment using 
numbers and experimental findings, maybe at risk of committing a self-fulfilling 
prophecy, a typical form of rather known pygamalion effect, quite common among 
scientists dealing with quantitative research methods and applications. Therefore, 
this section will be dealt with not only interpretation of reliability and validity of 
different frailty scales/indicators shown before but also the challenges of assuming 
the score results to individuals as sin qua non in frailty assessment to prospective 
readers be it practicing geriatricians, bio-gerontologists and/or policy makers, and 
other decision makers in aging field.
First, on reliability aspects, it is important for geriatricians, other clinicians 
handling senior citizens, clinician-scientists, policy makers as well as other readers 
alike to be aware of the fact that frailty scales/indicators scores derived from cited 
studies above do not in actual sense measure reliability at best. There is no doubt 
that no other statistic in published literature has been a subject of wide confusion 
than coefficient α for reliability test scores. Specifically, Cronbach’s α coefficient 
that at best displays homogeneity of test scores has been incorrectly associated 
with a quality indicator of internal stability score, a direct reflection of a reliability 
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estimate. This rather subtle cognitive error has been in existence in science for at 
least 60 years. It was formerly described by Cronbach via a seminal paper published 
in 1951 [42]. To simply describe the extent of the spread of the flaw, as well as the 
confusion therein, until the time this line you read was first typed by the author, at 
the peak of a COVID19 pandemic, the Cronbach’s paper published in Psychometrika 
back in 1951, had been cited more than 45,000 times in published literature world-
wide. Details about the flaws (as well as the resulting confusion) of Cronbach’s α 
as an index measure of reliability of test scores are beyond the scope of this book. 
However, just to give a glimpse to readers, I have decided to provide a narrative 
account of the fallacy behind usage of Cronbach’s α coefficient as a measure of reli-
ability of test results.
Cronbach’s α coefficient as a test statistic in principle is consistently and 
incorrectly taken as a measure of internal stability of test scores, and therefore 
an estimate of internal consistency. It has been shown that Cronbach’s α coef-
ficient cannot provide investigators that sort of information [43]. Cronbach’s α 
coefficient is at best the greatest lower bound to reliability estimate, and therefore 
almost always an underestimate of a reliability coefficient α for internal consis-
tency of test scores [43]. At this juncture, it is important to remind readers on 
what exactly is internal consistency of test scores results. Simply written, internal 
consistency of test score results refer to interrelatedness of a set of items, be it test 
scores results or any other of non-singular matrix scores [44]. It therefore follows 
that much of the confusion surrounding Cronbach’s α coefficient dates back to 
Cronbach’s paper of 1951 [42] in that Cronbach used internal consistency and 
homogeneity synonymously [44]. It is clear nowadays, therefore, that Cronbach’s 
α coefficient may attain values that are outside the scope of possible reliability 
scores from a single test result. I would like just to mention a solution to this chal-
lenge, just sparingly to include standard measurement errors in the form of the 
following equation:
 ( )+σ = σ −ρ +
/
y x x ’x
1 2
1  (1)
where ρx+x’+—test score reliability in a population, σx—standard deviation of a 
population of interest, and σy—standard measurement error of a sample of interest.
It is important to remind readers that application of standard measurement error 
as a measure of internal consistency of test scores assumes each individual score 
results originated from a test with the same accuracy [43]. Details of this method 
of assessing internal consistency, and therefore inherent reliability of any given test 
scores, are given in other published findings of the past [43–47].
In this chapter, I have hesitated myself from committing a rather common statis-
tical crime. It is well known that meta-analysis of findings from individual studies, 
customarily using forest plots, is an efficacious way of deriving effect size as well as 
identifying small and insignificant statistical results. However, I must admit there 
have been strong attempts to pool reliability and validity estimates from different 
studies here. The decision at the end, of not to include forest plots, from meta-anal-
ysis in this chapter, is based on the same philosophy, behind the chapter, namely, 
reliability and validity for test scores of sample estimates. On a frank note, there 
is profound heterogeneity reported from the study sample used for assessment of 
reliability and validity of frailty scales and indicators in publication database. This 
made all attempts toward “forest plotting” a futile exercise on philosophical grounds. 
It is quite obvious that given wealthy of statistical tests available to date, there were 
remedial measures to account for heterogeneity of those referred studies. However, 
given the fact that data were different from how they were conceptualized, and 
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not only in the way they were analyzed, made all those statistical tests available for 
estimating heterogeneity, a non-starter in this endeavor.
At large, these studies differ significantly on the basis of their designs. For 
instance, whereas findings in Table 1 reflected assessment of Cronbach’s alpha 
coefficient, for what was referred to as internal consistency, out of studies target-
ing Clinical Frailty Scale, the study by Rockwood and colleagues in Canada was 
conceived as a prospective observational study [20]. Moreover, Chong and col-
leagues’ study conducted in Singapore was designed in a retrospective fashion [23]. 
It therefore comes out automatic that total population at risk was a distinguishing 
feature between these two studies. Clearly, with prospective data, one can quantify 
population at risk, whereas in retrospective data, such a count is not possible. The 
difference in probability counts of risk between those two studies does not end 
in risk estimates. It blows out in any calculation involving probabilistic appoint-
ments, including the early stages of obtaining Cronbach’s α coefficient. Pooling 
out estimates from these two study designs (prospective vs. retrospective) is no 
difference from mixing oranges and mangoes together. Whereas the idea may seem 
useful in gastronomy, it is a statistical crime, equivalent to a third-degree murder 
in jurisprudence [48]. Details about the flaws in pooling estimates of retrospective 
and prospective designs together are described in length in mathematical statistical 
literature [49–52].
Apart from the design differences between studies whose estimates were 
pooled as means to assess reliability and validity in this chapter, heterogeneity is 
also suspected to be present from publication bias. Quite commonly in biomedi-
cal research and databases, studies are only published if they attain positive 
outcomes as per research questions designed by investigators. Whereas the 
message here is not to support the idea, as I personally believe in learning from 
findings with negative results from their hypothesized questions, I found it an 
important message to remind readers. It is quite possible that there were other 
studies left behind simply because they either failed to appear in press for what 
so ever reasons or they were left behind merely out of ignorance by the author 
during retrieval of information used to pool these data. At this point, it should 
be clear that there are quantitative mechanisms of assessing heterogeneity in 
statistical data [39, 40, 52–61]. However, those techniques are far behind abilities 
to correct what went wrong during design stage. It was therefore futile to justify 
application of those techniques to data that was conceived in either retrospective 
fashion or out of publication bias.
On a positive note, however, the findings from these studies do probably high-
light an important construct that is related to diminished ability of various body 
systems, currently coined as frailty. This is because in most of these studies, all of 
their domains (physical, psychological, or social) do reflect some deficiencies that 
are commonly associated with those of advanced age, who we may safely assume, to 
reflect a true concept of frailty. Until now, it must be born to the minds of read-
ers that the lack of gold standard decision rule for assessing frailty forces scholars 
to make comparisons to available tools. It is therefore a call to action for future 
researchers in aging research to consider design and development of more innova-
tive concepts and tools in assessment of frailty [62–64].
Lastly, and as a matter of urgent priority, geriatricians, aging research scientists 
as well as other practitioners and decision makers in health need to consider dif-
ferent population base in their future research on frailty. At present, there appears 
to be palpable evidence that demographic transition has started, and likely to 
mature soon, in parts of sub-Saharan Africa [65]. For instance, it is quite evident 
that Tanzania, just like other sub-Saharan African countries, has its population 
undergoing demographic transition [65], perhaps at a faster rate than what was 
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seen in Europe in the nineteenth century and early parts of twentieth century. It 
is clear that part of what may be termed as residual effects, in ascertaining factors 
associated with frailty and other aging-related concepts, to be better explained 
by environmental milieu found in sub-Saharan Africa, rather than the developed 
North. It is therefore a matter of intellectual maturity that future studies on quality 
indicators in frailty assessment will also be tested and validated in population 
found in the South.
Likewise, on a pioneering scale, global efforts in the interplay of mind and 
organosystemic degenerations in later life need a critical eye among aging research-
ers. At present, there is a lot of confusion not only among geropsychologists but 
even among clinician-scientists caring for the senior citizens across nations. For 
instance, there is a clear gap in research evidence on inability to characterize the 
cognitive domain in the illustration of the concept of frailty, in addition to clear 
discrepancies in how best to handle cognitive abnormalities in the oldest old. 
It also follows the logic that the current interventions and strategies in psycho-
social interventions the world over to be porous at best and segregate the senior 
citizens at worst. To this end, I propose that psychosocial challenges arising 
directly or indirectly from the aging process to be handled using data-based 
findings. Moreover, there is a desperate call for inductive research to deductive 
thinking in the science of geropsychology the world over. Short of that, most 
scales/indicators of frailty will have a lack-of-fit on the basis of their missing 
domain of the psyche.
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